Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Vitamin effect on homocystine levels does not affect Abeta levels in stroke patients

Jan. 22, 2009

Merck & Co. divulge new gamma-secretase modulators for Alzheimer's disease

Jan. 22, 2009

AVI reports positive results from phase I trial of AVI-4658 for DMD

Jan. 22, 2009

Parkinson's disease drug Trerief obtains marketing approval in Japan

Jan. 22, 2009

Alexza initiates phase IIb clinical trial of Staccato loxapine in migraine

Jan. 22, 2009

Novel mGluR5 receptor modulators with antipsychotic properties developed at GSK

Jan. 22, 2009

Recent Roche patent reports new antipsychotic tachykinin NK3 receptor antagonists

Jan. 22, 2009

Auris Medical commences phase IIb AM-111 trial in hearing loss

Jan. 21, 2009

Roche discloses novel tachykinin NK3 receptor antagonists

Jan. 21, 2009

New serotonin reuptake inhibitors and 5-HT1A receptor antagonists discovered at Wyeth

Jan. 21, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...